FLT3 and acute myeloid leukemia: To gain insights into the relationship between siglec expression and AML patient features, we compared the siglec expression in AML subgroups categorized by WBC count, PB blasts, BM blasts, NPM1 mutation, IDH1 R132 mutation and FLT3 mutation (Fig. 2B).